ExAblate® Neuro has been used to treat 30 Patients with Chronic Neurological Disorders such as Essential Tremor‚ Neuropathic Pain and Parkinson’s Disease

September 21, 2011

Clinical trials being conducted at the University of Virginia broadcast on WVTF radio

TIRAT CARMEL, Israel (September 21, 2011) – InSightec Ltd., the global leader in MR guided Focused Ultrasound (MRgFUS) technology, announced today that its investigational ExAblate® Neuro system has been used in clinical studies to treat 30 patients suffering from chronic neurological disorders. The clinical trials are being conducted by functional neurosurgeons, neurologists and neuroradiologists in Switzerland, and the US to evaluate the safety and initial efficacy of the system for treating Essential Tremor, Neuropathic Pain and Parkinson’s Disease. The system is limited to investigational use only .

“ExAblate Neuro has demonstrated the ability to ablate targets deep in the brain with high precision. The initial results have been encouraging. This gives us hope that this treatment alternative could in the future become a significant addition to the physicians’ armamentarium in treating functional brain diseases.” he continued.
The intra-operative image guidance built into ExAblate Neuro is designed to allow precision control and accurate delivery to the planned target with continuous real time feedback throughout the treatment.

Ongoing clinical research will evaluate the ability of this technology to reduce the risk of complications and side-effects. It may provide a treatment option for those individuals where surgery is currently not an option, or refuse an intervention of the brain.

Balance of this item includes this link: Click here to view a story about the clinical trials being conducted at the University of Virginia aired on WVTF radio on Sept 20.

Also see item in Globes (Israel): http://www.globes.co.il/serveen/globes/docview.asp?did=1000684600&fid=1725